Literature DB >> 29039487

Functional analysis of HOXA10 and HOXB4 in human medulloblastoma cell lines.

Ricardo Bonfim-Silva1, Fernanda Ursoli Ferreira Melo2, Carolina Hassibe Thomé3, Kuruvilla Joseph Abraham4, Fábio Augusto Labre De Souza1, Fernando Silva Ramalho5, Hélio Rubens Machado6, Ricardo Santos De Oliveira6, Angelo A Cardoso7, Dimas Tadeu Covas8, Aparecida Maria Fontes1.   

Abstract

Medulloblastoma (MB) is a malignant childhood brain tumor which at molecular level is classified into at least four major subtypes: WNT, SHH, group C and group D differing in response to treatment. Previous studies have associated changes in expression levels and activation of certain HOX genes with MB development. In the present study, we investigate the role of HOX genes in two attributes acquired by tumor cells: migration and proliferation potential, as well as, in vivo tumorigenic potential. We analyzed UW402, UW473, DAOY and ONS-76 human pediatric MB cell lines and cerebellum primary cultures. Two-color microarray-based gene expression analysis was used to identify differentially expressed HOX genes. Among the various HOX genes significantly overexpressed in DAOY and ONS-76 cell lines compared to UW402 and UW473 cell lines, HOXA10 and HOXB4 were selected for further analysis. The expression levels of these HOX genes were validated by real-time PCR. A mouse model was used to study the effect of the HOXA10 and HOXB4 genes on the in vivo tumorigenic potential and the in vitro proliferative and migration potential of MB cell lines. Our results show that the inhibition of HOXA10 in DAOY cell line led to increased in vitro cell migration while in vitro cell proliferation or in vivo tumorigenic potential were unaffected. We also observed that induced expression of HOXB4 in the UW473 cell line significantly reduced in vitro cell proliferation and migration capability of UW473 cells with no effect on the in vivo tumorigenicity. This suggests that HOXA10 plays a role in migration events and the HOXB4 gene is involved in proliferation and migration processes of medulloblastoma cells, however, it appears that these genes are not essential for the tumorigenic process of these cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29039487     DOI: 10.3892/ijo.2017.4151

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.

Authors:  Andrea Martins-da-Silva; Mirella Baroni; Karina Bezerra Salomão; Pablo Ferreira das Chagas; Ricardo Bonfim-Silva; Lenisa Geron; Gustavo Alencastro Veiga Cruzeiro; Wilson Araújo da Silva; Carolina Alves Pereira Corrêa; Carlos Gilberto Carlotti; Rosane Gomes de Paula Queiroz; Suely Kazue Nagahashi Marie; Silvia Regina Brandalise; José Andrés Yunes; Carlos Alberto Scrideli; Elvis Terci Valera; Luiz Gonzaga Tone
Journal:  Cell Mol Neurobiol       Date:  2022-04-02       Impact factor: 5.046

2.  Integrated Bioinformatic Analysis of the Correlation of HOXA10 Expression with Survival and Immune Cell Infiltration in Lower Grade Glioma.

Authors:  Ting Wang; Mingqian Liu; Ming Jia
Journal:  Biochem Genet       Date:  2022-07-14       Impact factor: 2.220

3.  HOXA10‑AS: A novel oncogenic long non‑coding RNA in glioma.

Authors:  Cheng-Ya Dong; Jiayue Cui; Dian-He Li; Qi Li; Xin-Yu Hong
Journal:  Oncol Rep       Date:  2018-08-21       Impact factor: 3.906

4.  HOXB4 inhibits the proliferation and tumorigenesis of cervical cancer cells by downregulating the activity of Wnt/β-catenin signaling pathway.

Authors:  Dan Lei; Wen-Ting Yang; Peng-Sheng Zheng
Journal:  Cell Death Dis       Date:  2021-01-21       Impact factor: 8.469

5.  Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids.

Authors:  Lei Li; Zhujia Ye; Sai Yang; Hao Yang; Jing Jin; Yingying Zhu; Jinsheng Tao; Siyu Chen; Jiehan Xu; Yanying Liu; Weihe Liang; Bo Wang; Mengzhu Yang; Qiaoyun Huang; Zhiwei Chen; Weimin Li; Jian-Bing Fan; Dan Liu
Journal:  Clin Epigenetics       Date:  2021-10-07       Impact factor: 6.551

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.